NCBiotech News

When you get an injection, apply eye drops, swallow cough syrup or apply mascara, there’s a good chance that the product may have been packaged by a machine made by groninger, a German company with a growing U.S. headquarters in Charlotte.

KNOW Bio, LLC, a Durham life science incubator, is merging its gut instinct with the scientific method by pursuing a belief that its nitric oxide-based platform has therapeutic applications for conditions of the gastrointestinal tract.

The Economic Development Partnership of North Carolina (EDPNC) is once again registering North Carolina manufacturers for its annual Go Global Road Show, which is being presented April 1-4 in four locations across the state.

Seafood innovators from around the world will converge in North Carolina’s coastal business and recreational magnet of Wilmington April 23 and 24 for the second two-day Fish 2.0, workshop.

bluebird bio, a Massachusetts-based gene and cell therapy company, has opened its first wholly owned manufacturing facility in Durham amid cheers from state leaders.

Lenoir is a small town in the rural foothills, away from the state’s renowned technology hubs. But it's home to Exela Pharma Sciences, a fast-growing manufacturer of generic sterile injectable medications backed by venture capital, government grants and loans, investments by family and friends and personal funds of founder Phanesh Koneru. In its first decade it has grown to 320 employees, and it’s hiring more.

Pairwise, one of the Triangle area’s fast-growing agriculture and food biotech companies, has licensed some advanced CRISPR genome editing technologies from two prestigious Boston institutions to expand its crop-editing applications and bring new foods to market.

Fervent Pharmaceuticals, a clinical-stage drug development company based in Greenville, has announced positive results from its Phase 2A clinical trial of FP-101, a non-hormonal, non-herbal, non-antidepressant treatment of the vasomotor symptoms that accompany menopause.

Cary-based agricultural technology company Verdesian Life Sciences' global workforce of 225 strives to advance the company’s goal “to enable a sustainable future for farmers through nutrient use efficiency.”

Durham-based Aerie Pharmaceuticals, a developer of therapies for eye diseases, has received approval from the U.S. Food and Drug Administration to begin selling Rocklatan, a once-daily eye drop for reducing high intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Norman E. “Ned” Sharpless, M.D., who is currently director of the National Cancer Institute, was named acting commissioner Tuesday to replace FDA Commissioner Scott Gottlieb, M.D. Gottlieb unexpectedly announced his resignation March 5.

North Carolina’s Research Triangle region is among the nation’s largest and fastest-growing markets in the life sciences, according to a new report by Los Angeles-based CBRE Group, the world’s largest commercial real estate services and investment firm.

To add momentum to the fast-growing field of precision medicine, Durham-based IQVIA has launched a patented new technology platform for life science customers to access big data needed for a wide range of research activities.

The Personalized Medicine Coalition promotes policies that support personalized medicine and encourages physicians to integrate personalized medicine in clinical settings.

Paris-based biotechnology company Cellectis announced plans today to invest nearly $70 million and create 200 jobs in Raleigh, at what will become its first North American manufacturing facility.